It just occurred to me that BrainCells Inc is trying to out-licence Coluracetam for the treatment of co-morbid depression and anxiety. (http://www.braincell...ipeline/bci-540). Does this mean they're trying to get a company to bring it to market? Their clinical trials were concluded in June of last year, I wonder what the hold-up is on getting this to market.
I'm thinking it might be a really expensive synth or something. Maybe difficult enough to make that would make it profitable to patent it in medicine form. Not sure, just speculation.
But honestly I think CH is more likely to get something like phenylpiracetam before coluracetam... although I can't find even one supplier of phenylpiracetam in China, and there's at least a couple for the coluracetam so maybe I'm wrong on that.